Buy Dishman Pharma; target of Rs 177: Angel Broking

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Angel Broking`s research report on Dishman Pharma “For 1QFY2015, Dishman Pharmaceuticals and Chemicals (Dishman) announced better-than-expected numbers on the sales front, but lower-than-expected OPM and net profit. The company posted a revenue of Rs362cr (V/s an expected Rs332cr), up 18.1% yoy. The OPM came in at 20.5% (V/s an expected 23.0%), a yoy dip of 730bp. The dip in the margin is on account of the 431bp dip in the gross margin and a 21.3% and 32.8% yoy growth in staff and other expenditure, respectively. The PAT for the quarter came in at Rs24cr, a yoy de-growth of 18.6% yoy. We maintain our Buy rating on the stock with a price target of Rs177.” “The company posted a revenue of Rs362cr (V/s an expected Rs332cr), up 18.1% yoy. The sales growth was led by the MM segment, which grew by 31.0% yoy, while CRAMS posted a yoy growth of 12.7%. The OPM came in at 20.5% V/s an expected 23.0% and V/s 27.8% in the corresponding quarter of last year. The dip in OPM is on back of the 431bp dip in the gross margin (71.1% V/s 75.4% in the corresponding period of last year) and a 21.3% and 32.8% yoy growth in staff and other expenditure, respectively. A higher depreciation expenditure during the period led the PAT to come in at Rs24cr, a yoy de-growth of 18.6% yoy. This was much lower than the expected PAT of Rs37cr, due to a higher-than-expected interest expenditure during the period.” “We expect Dishman’s net sales and net profit to come in at Rs1,662cr and Rs178cr, respectively, in FY2016. At current levels, Dishman is trading at 8.1x and 6.7x FY2015E and FY2016E earnings, respectively. We believe the current valuations are attractive, hence, we maintain our Buy recommendation on the stock with a price target of Rs177,” says Angel Broking research report.

For all recommendations, click here 

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More